Team:Lyon-INSA-ENS/Project/Achievement

From 2011.igem.org

(Difference between revisions)
 
(26 intermediate revisions not shown)
Line 26: Line 26:
  <div id="language";>
  <div id="language";>
-
         <img src="https://static.igem.org/mediawiki/2011/0/0e/Drapeau_francais.jpg"; width=20px; /> <a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Project/AchievementFr">Version Francaise</a>
+
         <img src="https://static.igem.org/mediawiki/2011/0/0e/Drapeau_francais.jpg"; width=20px; /> <a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Project/AchievementFr">Version Fran&ccedil;aise</a>
  </div>
  </div>
-
<div class="contenugrand2;">
+
<div class="contenugrand2";>
 +
   
-
<h1><font color="green"> A race between two different strategies was used to obtain the first part </font></h1> <HR>
+
      <br><br><br/><br/>
 +
      <p id="top"> <font color="green" size="6">
 +
              Achievements<br><HR>
 +
              <br/>
 +
          </font>
 +
      </p>
-
<p style="line-height:1.5em">
+
<br><br>
-
In E. coli the curli-producing system is organized in two divergeant operons with the genes
+
<p style="line-height:1.5em;text-indent:0%;">
-
csgA, csgB and csgC on one side and csgD, csgE, csgF and csgG of the other one. So to
+
<ul style="list-style-image:url('https://static.igem.org/mediawiki/2011/4/4d/Chek.JPG'); margin-left:50px;">
-
achieve the first approach of the project, it is necessary to begin by the creation of three "sub-
+
-
parts": the first one would be the part with the sole promoter PrcnA, the second would be the
+
-
part with the genes csgA and csgB and final one would be the part with the genes csgE, csgF
+
-
and csgG.
+
-
<br/> <br/>
+
-
</p>
+
-
<p style="line-height:1.5em">
+
<li>We lived a <b>great human experience</b>, met new friends and <b>had fun</b>!!</li><br><br>
-
The synthesis of this first DNA part (the cobalt-inducible promoter Prcn-csgBAEFG, which is
+
<li>We acquired <b>new knowledge and competencies</b> dealing with scientific and logistic issues.</li><br><br>
-
designed to induce formation of a biofilm and to promote cell adhesion) was conceived as as a
+
<li>We submitted <b> <a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Project/Parts">2 documented parts</a></b> to the registry and showed that they work as expected.</li><br><br>
-
competition between two methods: a completely synthetic approach, and a "manual" method
+
<li>We characterized a <b><a href="http://partsregistry.org/Part:BBa_K342003">pre-existing part</a></b>.</li><br><br>
-
involving PCR steps followed by ligations. <br/>
+
<li>We <b><a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Sponsors/Collaboration">collaborated</a></b> with another iGEM team : TU Delft.</li><br><br>
-
</p>
+
<li><p style="line-height:1.5em;text-indent:0%;">
 +
We <a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Communication/Main">presented our project and Synthetic Biology</a> in many ways :  in different <b>websites</b>,<br/> in <b>newspapers</b>, on the <b>radio</b>, on <b>TV</b>, … and even <b>in music</b> ; in order to inform a public <br/>as varied as possible.
 +
</p></li><br><br>
 +
<li>We <b>get our project close to reality</b> meeting experts to consider <b> <a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Project/Industrialization">industrialization</a></b>.</li><br/><br/>
 +
<li>We explored <b><a href="https://2011.igem.org/Team:Lyon-INSA-ENS/Safety/Intro"> safety implications </a></b> of the project as a whole.</li><br/>
-
<ul style="list-style-type:circle;margin-left:30%;">            
+
</ul></p>
-
              <li style="line-height : 1.5em"> The first approach consist in ordering the whole part at a private company (Genecust).</li>
+
<br/><br/>
-
              <br/>
+
-
              <li style="line-height : 1.5em"> The second approach was to made it directly at the bench, this approach included three
+
-
steps: first the amplification by PCR of each of the sub parts, second a mutagenesis
+
-
step to remove all the natural internal EcoRI sites located in the sub parts, and finally
+
-
the ligation of these parts.</li>
+
-
              <br/>
+
-
        </ul>
+
-
 
+
-
<p style="line-height:1.5em">
+
-
Both approches were initiated at the same time, and if the second one allowed us to obtain
+
-
PCR amplifications of the correct size (see figure) and a complete Prcn-csgBAEFG
+
-
construction, unfortunately sequencing analysis revealed unexpected mutations that were not
+
-
removed before reception of the whole part made by Genecust. In brief the "click and order"
+
-
strategy wins the race !
+
-
</p>
+
 +
<br><br><br><br><br><br><br><br><br><br><br>
</div>
</div>
-
 
</html>
</html>
{{Lyon-INSA-ENS/footer}}
{{Lyon-INSA-ENS/footer}}

Latest revision as of 23:33, 21 September 2011









Achievements





  • We lived a great human experience, met new friends and had fun!!


  • We acquired new knowledge and competencies dealing with scientific and logistic issues.


  • We submitted 2 documented parts to the registry and showed that they work as expected.


  • We characterized a pre-existing part.


  • We collaborated with another iGEM team : TU Delft.


  • We presented our project and Synthetic Biology in many ways : in different websites,
    in newspapers, on the radio, on TV, … and even in music ; in order to inform a public
    as varied as possible.



  • We get our project close to reality meeting experts to consider industrialization.


  • We explored safety implications of the project as a whole.

















ENS assystem Biomérieux INSA INSA